RELATIVE CONCENTRATIONS OF ENDOTOXIN-BINDING PROTEINS IN BODY-FLUIDS DURING INFECTION

被引:77
作者
OPAL, SM
PALARDY, JE
MARRA, MN
FISHER, CJ
MCKELLIGON, BM
SCOTT, RW
机构
[1] BROWN UNIV,SCH MED,PAWTUCKET,RI
[2] INCYTE PHARMACEUT,PALO ALTO,CA
[3] CLEVELAND CLIN FDN,CLEVELAND,OH
关键词
D O I
10.1016/S0140-6736(94)91767-1
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Endotoxin initiates the systemic inflammatory response, haemodynamic changes, and multi-organ failure that may occur as a consequence of systemic gram-negative bacterial infection. The serum protein lipopolysaccharide-binding protein (LBP) binds to the lipid A component of bacterial endotoxin and facilitates its delivery to the CD14 antigen on the macrophage, where proinflammatory cytokines are released and a cascade of host mediators is initiated. The neutrophil granular protein bactericidal/permeability-increasing protein (BPI) competes with LBP for endotoxin binding and functions as a molecular antagonist of LBP-endotoxin interactions. We have measured concentrations of both proteins in body fluids from 49 consecutive patients. In 16 of 17 samples of fluid from closed-space infections, BPI was present in greater concentration than LBP (median BPI/LBP ratio 7.6 [95% CI 2.32-22.1]), The ratio of BPI and LBP was not significantly different from 1.0 in abdominal fluid from 10 patients with peritonitis (ratio 0.235 [0.18-0.47]), whereas the BPI/LBP ratio was low in 22 non-infected body fluids (0.01 [0.001-0.04]) and concentrations of both proteins approached those in normal human plasma. BPI concentrations were directly correlated with the quantity of neutrophils within clinical samples (r(s) = 0.81, p < 0.0001). Thus, within abscess cavities BPI is available in sufficient quantities for effective competition with LBP for endotoxin. BPI may attenuate the local inflammatory response and the systemic toxicity of endotoxin release during gram-negative infections.
引用
收藏
页码:429 / 431
页数:3
相关论文
共 22 条
  • [1] THE PATHOGENESIS OF SEPSIS
    BONE, RC
    [J]. ANNALS OF INTERNAL MEDICINE, 1991, 115 (06) : 457 - 469
  • [2] PLASMA ENDOTOXIN AS A PREDICTOR OF MULTIPLE ORGAN FAILURE AND DEATH IN SYSTEMIC MENINGOCOCCAL DISEASE
    BRANDTZAEG, P
    KIERULF, P
    GAUSTAD, P
    SKULBERG, A
    BRUUN, JN
    HALVORSEN, S
    SORENSEN, E
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1989, 159 (02) : 195 - 204
  • [3] PLASMA CYTOKINE AND ENDOTOXIN LEVELS CORRELATE WITH SURVIVAL IN PATIENTS WITH THE SEPSIS SYNDROME
    CASEY, LC
    BALK, RA
    BONE, RC
    [J]. ANNALS OF INTERNAL MEDICINE, 1993, 119 (08) : 771 - 778
  • [4] THE EFFICACY OF COMBINATION IMMUNOTHERAPY IN EXPERIMENTAL PSEUDOMONAS SEPSIS
    CROSS, AS
    OPAL, SM
    PALARDY, JE
    BODMER, MW
    SADOFF, JC
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1993, 167 (01) : 112 - 118
  • [5] HUMAN NEUTROPHIL BACTERICIDAL PERMEABILITY-INCREASING PROTEIN REDUCES MORTALITY-RATE FROM ENDOTOXIN CHALLENGE - A PLACEBO-CONTROLLED STUDY
    FISHER, CJ
    MARRA, MN
    PALARDY, JE
    MARCHBANKS, CR
    SCOTT, RW
    OPAL, SM
    [J]. CRITICAL CARE MEDICINE, 1994, 22 (04) : 553 - 558
  • [6] COMPETITION BETWEEN RBPI(23), A RECOMBINANT FRAGMENT OF BACTERICIDAL/PERMEABILITY-INCREASING PROTEIN, AND LIPOPOLYSACCHARIDE (LPS)-BINDING PROTEIN FOR BINDING TO LPS AND GRAM-NEGATIVE BACTERIA
    GAZZANOSANTORO, H
    MESZAROS, K
    BIRR, C
    CARROLL, SF
    THEOFAN, G
    HORWITZ, AH
    LIM, E
    ABERLE, S
    KASLER, H
    PARENT, JB
    [J]. INFECTION AND IMMUNITY, 1994, 62 (04) : 1185 - 1191
  • [7] GRAY PW, 1989, J BIOL CHEM, V264, P9595
  • [8] COMPETITION BETWEEN BACTERICIDAL PERMEABILITY-INCREASING PROTEIN AND LIPOPOLYSACCHARIDE-BINDING PROTEIN FOR LIPOPOLYSACCHARIDE BINDING TO MONOCYTES
    HEUMANN, D
    GALLAY, P
    BETZCORRADIN, S
    BARRAS, C
    BAUMGARTNER, JD
    GLAUSER, MP
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1993, 167 (06) : 1351 - 1357
  • [9] CRYSTAL-STRUCTURE OF AN ENDOTOXIN-NEUTRALIZING PROTEIN FROM THE HORSESHOE-CRAB, LIMULUS ANTI-LPS FACTOR, AT 1.5 ANGSTROM RESOLUTION
    HOESS, A
    WATSON, S
    SIBER, GR
    LIDDINGTON, R
    [J]. EMBO JOURNAL, 1993, 12 (09) : 3351 - 3356
  • [10] MARRA MN, 1992, J IMMUNOL, V148, P532